Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,100
-550 (-4.72%)
At close: Apr 9, 2026
Market Cap272.67B +36.4%
Revenue (ttm)15.20B +83.7%
Net Income273.36M
EPS11.00
Shares Out24.17M
PE Ratio997.46
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume124,836
Average Volume231,209
Open11,660
Previous Close11,650
Day's Range10,960 - 11,780
52-Week Range7,130 - 13,450
Beta0.07
RSI49.26
Earnings DateMay 15, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements